Is Overexpression of TWIST, a Transcriptional Factor, a Prognostic Biomarker of Head and Neck Carcinoma? Evidence from Fifteen Studies

Overview

Journal Sci Rep

Specialty Science

Date 2015 Dec 15

PMID 26656856

Citations 7

Authors

Xianlu Zhuo

Huanli Luo

Aoshuang Chang

Dairong Li

Houyu Zhao

Qi Zhou

Affiliations

Soon will be listed here.

Abstract

TWIST, a basic helix-loop-helix transcription factor, has been indicated to play a critical role in the progression of numerous malignant disorders. Published data on the significance of TWIST expression in head and neck carcinoma (HNC) risk have yielded conflicting results. Thus, we conducted a quantitative meta-analysis to obtain a precise estimate of this subject. After systematic searching and screening, a total of fifteen studies using immunohistochemistry for TWIST detection were included. The results showed that TWIST positive expression rate in HNC tissues was higher than that in normal tissues. TWIST expression might have a correlation with clinical features such as low differentiation, advanced clinical stage, presence of lymph node metastasis, distant metastasis and local recurrence (P < 0.05) , but not with age, gender, T stage and smoking as well as drinking (P > 0.05). In addition, over-expression of TWIST was a prognostic factor for HNC (HR = 1.92, 95% CI = 1.13-3.25). The data suggested that TWIST might play critical roles in cancer progression and act as a prognostic factor for HNC patients.

Citing Articles

Can initial apparent diffusion coefficient and tumour volume predict future metastases in treatment-naive patients with laryngeal squamous cell carcinoma.

Topcuoglu E Pol J Radiol. 2024; 89:e267-e272.

PMID: 38938659 PMC: 11210382. DOI: 10.5114/pjr/187675.

Prognostic and clinicopathological value of Twist expression in esophageal cancer: A meta-analysis.

Song W, Wang S, Zhou S, Wu D, Xie J, Liu T World J Gastrointest Oncol. 2022; 14(9):1874-1886.

PMID: 36187399 PMC: 9516646. DOI: 10.4251/wjgo.v14.i9.1874.

ET-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells via the microRNA-489-3p /TWIST Axis.

Tzeng H, Tang C, Tsai C, Chiu C, Wu M, Yen Y Onco Targets Ther. 2021; 14:5005-5018.

PMID: 34675545 PMC: 8502871. DOI: 10.2147/OTT.S294312.

Signaling pathways promoting epithelial mesenchymal transition in oral submucous fibrosis and oral squamous cell carcinoma.

Shetty S, Sharma M, Fonseca F, Jayaram P, Tanwar A, Kabekkodu S Jpn Dent Sci Rev. 2020; 56(1):97-108.

PMID: 32874377 PMC: 7452314. DOI: 10.1016/j.jdsr.2020.07.002.

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma.

Alfieri S, Carenzo A, Platini F, Serafini M, Perrone F, Galbiati D Cancers (Basel). 2020; 12(4).

PMID: 32283719 PMC: 7225924. DOI: 10.3390/cancers12040922.

References

Wang N, Luo H, Yin G, Dong C, Xu M, Chen G . Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma. Clin Dev Immunol. 2013; 2013:589423. PMC: 3830792. DOI: 10.1155/2013/589423. View

Lei P, Ding D, Xie J, Wang L, Liao Q, Hu Y . Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma. Oncol Lett. 2015; 10(1):417-421. PMC: 4487166. DOI: 10.3892/ol.2015.3246. View

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

Gonzalez D, Medici D . Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014; 7(344):re8. PMC: 4372086. DOI: 10.1126/scisignal.2005189. View

Qiao B, Chen Z, Hu F, Tao Q, Lam A . BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal transition of oral epithelial cells. Exp Mol Pathol. 2013; 95(1):57-61. DOI: 10.1016/j.yexmp.2013.05.004. View

Scanlon C, Van Tubergen E, Inglehart R, DSilva N . Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res. 2012; 92(2):114-21. PMC: 3545688. DOI: 10.1177/0022034512467352. View

Wu T, Jia J, Xiong X, He H, Bu L, Zhao Z . Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinoma. PLoS One. 2014; 8(12):e83869. PMC: 3875533. DOI: 10.1371/journal.pone.0083869. View

Jouppila-Matto A, Narkio-Makela M, Soini Y, Pukkila M, Sironen R, Tuhkanen H . Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer. 2011; 11:350. PMC: 3173446. DOI: 10.1186/1471-2407-11-350. View

Mao Y, Zhang N, Xu J, Ding Z, Zong R, Liu Z . Significance of heterogeneous Twist2 expression in human breast cancers. PLoS One. 2012; 7(10):e48178. PMC: 3485060. DOI: 10.1371/journal.pone.0048178. View

10.

Agajanian M, Runa F, Kelber J . Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. Biochem Biophys Res Commun. 2015; 465(3):606-12. DOI: 10.1016/j.bbrc.2015.08.071. View

11.

Steinestel K, Eder S, Schrader A, Steinestel J . Clinical significance of epithelial-mesenchymal transition. Clin Transl Med. 2014; 3:17. PMC: 4094902. DOI: 10.1186/2001-1326-3-17. View

12.

Wu K, Yang M . Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Biosci Rep. 2011; 31(6):449-55. DOI: 10.1042/BSR20100114. View

13.

Smith A, Teknos T, Pan Q . Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol. 2012; 49(4):287-92. PMC: 3586749. DOI: 10.1016/j.oraloncology.2012.10.009. View

14.

Fan C, Wang T, Cheng Y, Jiang S, Cheng C, Lee A . Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2013; 139(10):1735-44. DOI: 10.1007/s00432-013-1499-9. View

15.

van Nieuwenhuizen A, Buffart L, Brug J, Leemans C, Verdonck-de Leeuw I . The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol. 2014; 51(1):1-11. DOI: 10.1016/j.oraloncology.2014.09.002. View

16.

Fakhry C, Westra W, Li S, Cmelak A, Ridge J, Pinto H . Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100(4):261-9. DOI: 10.1093/jnci/djn011. View

17.

Machiels J, Lambrecht M, Hanin F, Duprez T, Gregoire V, Schmitz S . Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep. 2014; 6:44. PMC: 4047945. DOI: 10.12703/P6-44. View

18.

Liang X, Zheng M, Jiang J, Zhu G, Yang J, Tang Y . Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral Oncol. 2010; 47(2):92-7. DOI: 10.1016/j.oraloncology.2010.11.014. View

19.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

20.

Chang A, Liu Y, Ayyanathan K, Benner C, Jiang Y, Prokop J . An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors. Genes Dev. 2015; 29(6):603-16. PMC: 4378193. DOI: 10.1101/gad.242842.114. View